Mölnlycke establishes first wound care manufacturing site in China

Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the com...

November 6, 2025 | Thursday | News
Omron invests in South Korean healthcare startup Sky Labs

South Korea-based healthcare startup Sky Labs has attracted investments with OMRON Ventures, Omron Group's ent...

November 6, 2025 | Thursday | News
Novo Nordisk launches Wegovy in Hong Kong for weight management

Novo Nordisk has announced the launch of Wegovy® in Hong Kong, now available at private clinics and selected pharmac...

November 4, 2025 | Tuesday | News
4DMT and Otsuka ink deal worth $336 M to advance eye disease treatment in APAC

4D Molecular Therapeutics has announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialise ...

November 4, 2025 | Tuesday | News
Thailand’s Life Sciences Push Gains Business Momentum

Over the past few years, it has become evident that Thailand is undergoing a significant transformation into a hub of li...

November 2, 2025 | Sunday | Opinion
Boehringer Ingelheim acquires license of autoimmune drug from Japan's Kyowa Kirin for € 640 M

German firm Boehringer Ingelheim has licensed a pre-clinical programme from Japan's Kyowa Kirin to develop a potential f...

November 3, 2025 | Monday | News
Roche inks nearly $1 B deal with China's Qyuns Therapeutics for respiratory disease treatment

China's Qyuns Therapeutics has entered into a global exclusive collaboration and license agreement with F. Hoffmann-La R...

November 3, 2025 | Monday | News
Thermo Fisher buys Clario for $8.9 B offering deeper clinical insights

Thermo Fisher Scientific Inc., the world leader in serving science, has announced a definitive agreement to acquire Clar...

October 31, 2025 | Friday | News
Everest Medicines inks $89 M deal with NovaBridge for treating eye disorders in Asia

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commer...

October 31, 2025 | Friday | News
Korea's SK pharmteco and LOTTE BIOLOGICS partner to strengthen global ADC CDMO capabilities

South Korea-based SK pharmteco and LOTTE BIOLOGICS have signed a Letter of Intent (LOI) for a strategic collaboration to...

October 30, 2025 | Thursday | News
IASO Bio partners with GC Cell to bring CAR-T therapy to Korea

Nanjing IASO Biotechnology has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso" (Equecab...

October 31, 2025 | Friday | News
Co-Diagnostics partners with Arabian Eagle to localise Co-Dx™ PCR platform across Middle East

US-based Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of m...

October 29, 2025 | Wednesday | News
Japan's Olympus launches new surgical energy device for hemostatic cutting and Vessel Sealing

Japan-based medtech company Olympus Corporation has announced the launch of THUNDERBEAT™ II, the next generation h...

October 28, 2025 | Tuesday | News
SK Biopharma launches JV with Eurofarma for AI-based epilepsy management platform

South Korea-based SK Biopharmaceuticals has announced the establishment of Mentis Care, Inc., a joint venture (JV) with ...

October 23, 2025 | Thursday | News
Chinese startup Phrontline Biopharma joins hands with Samsung Bioepis to co-develop ADC assets

South Korea-based Samsung Bioepis Co., Ltd. and Chinese startup Phrontline Biopharma, a clinical-stage biotechnology com...

October 21, 2025 | Tuesday | News
Japan's Chugai inks $1.08 B deal with Rani Therapeutics for multiple high-value therapeutics

Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...

October 21, 2025 | Tuesday | News
Algorae teams up with Cadila Pharma to launch two generic medicines in Australian and New Zealand markets

Australia-based AI-enabled pharmaceutical company Algorae Pharmaceuticals has entered into a binding term sheet with Cad...

October 21, 2025 | Tuesday | News
Samsung partners with Grail in $110 M deal to expand early cancer testing across Asia

South Korea's Samsung C&T (SCT), Samsung Electronics (SEC), and US-based GRAIL, Inc. have signed a binding Letter of...

October 21, 2025 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls